eMotiv
Developing digital therapeutics for easy screening and treatment of ADHD
Developing digital therapeutics for easy screening and treatment of ADHD
eMotiv is a Korean startup founded in 2020 with the slogan "Developing digital therapeutics for easy screening and treatment of ADHD." The company's vision is to provide digital solutions for mental health care by analyzing data and offering continuous treatment. Their innovative approach addresses the current challenges of costly and time-consuming diagnosis and treatment of ADHD. With a user-friendly mobile application, eMotiv has gamified the screening and treatment process for ADHD, providing a fun and engaging experience for children while minimizing the risks of side effects associated with traditional treatments. The company recently secured a KRW2.30B Seed Round investment on 01 November 2023, with funding from MYSC and the Korea Credit Guarantee Fund. eMotiv is pushing the boundaries in digital therapeutics and is poised for significant growth in the mental health care sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | KRW2.30B | 2 |
|
01 Nov 2023 |
| Seed Round | KRW400.00M | 3 |
|
19 Oct 2021 |
No recent news or press coverage available for eMotiv.
We care about your data, and we'd love to use cookies make your experience better.
